Bionano Genomics, Inc. SEC filings BNGO
Bionano Genomics, Inc. has 629 filings in SEC EDGAR's recent list, going back to Aug 31, 2007. Its latest annual report, Form ARS, was filed on Apr 2, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 10, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 14, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Sep 16, 2025 | — |
| CORRESP | Letter to the SEC | Sep 11, 2025 | — |
| CORRESP | Letter to the SEC | Sep 11, 2025 | — |
| UPLOAD | Letter from the SEC | Aug 1, 2025 | — |
| DRS | Filing | Jul 30, 2025 | — |
| EFFECT | Filing | Jan 10, 2025 | — |
| CORRESP | Letter to the SEC | Jan 8, 2025 | — |
| UPLOAD | Letter from the SEC | Jan 8, 2025 | — |
| EFFECT | Filing | Aug 12, 2024 | — |
| CORRESP | Letter to the SEC | Aug 8, 2024 | — |
| UPLOAD | Letter from the SEC | Aug 7, 2024 | — |
| D | Filing | Jul 10, 2024 | — |
| EFFECT | Filing | Jun 20, 2024 | — |
| CORRESP | Letter to the SEC | Jun 17, 2024 | — |
| UPLOAD | Letter from the SEC | Jun 14, 2024 | — |
| D | Filing | Jun 5, 2024 | — |
| EFFECT | Filing | Nov 6, 2023 | — |
| CORRESP | Letter to the SEC | Nov 2, 2023 | — |
| UPLOAD | Letter from the SEC | Nov 2, 2023 | — |
| D | Filing | Oct 27, 2023 | — |
| 25-NSE | Delisting notice | Aug 17, 2023 | — |
| EFFECT | Filing | May 10, 2023 | — |
| CORRESP | Letter to the SEC | May 8, 2023 | — |
| UPLOAD | Letter from the SEC | Mar 17, 2023 | — |
| POSASR | Filing | Mar 9, 2023 | — |
| CT ORDER | Filing | Nov 18, 2022 | — |
| UPLOAD | Letter from the SEC | Jul 29, 2022 | — |
| CORRESP | Letter to the SEC | Jul 18, 2022 | — |
| CORRESP | Letter to the SEC | Jul 8, 2022 | — |
| CT ORDER | Filing | Jul 5, 2022 | — |
| UPLOAD | Letter from the SEC | Jun 23, 2022 | — |
| D | Filing | Oct 25, 2021 | — |
| CT ORDER | Filing | May 4, 2021 | — |
| EFFECT | Filing | Aug 25, 2020 | — |
| CORRESP | Letter to the SEC | Aug 21, 2020 | — |
| UPLOAD | Letter from the SEC | Aug 21, 2020 | — |
| EFFECT | Filing | Jul 7, 2020 | — |
| DEFR14A | Defr 14a | Jun 17, 2020 | — |
| UPLOAD | Letter from the SEC | May 20, 2020 | — |
| PRER14A | Filing | May 13, 2020 | — |
| POS EX | Filing | Apr 2, 2020 | — |
| EFFECT | Filing | Apr 1, 2020 | — |
| CORRESP | Letter to the SEC | Apr 1, 2020 | — |
| CORRESP | Letter to the SEC | Apr 1, 2020 | — |
| EFFECT | Filing | Mar 19, 2020 | — |
| CORRESP | Letter to the SEC | Mar 17, 2020 | — |
| UPLOAD | Letter from the SEC | Mar 17, 2020 | — |
| UPLOAD | Letter from the SEC | Mar 17, 2020 | — |
| EFFECT | Filing | Oct 21, 2019 | — |
| POS EX | Filing | Oct 21, 2019 | — |
| CORRESP | Letter to the SEC | Oct 16, 2019 | — |
| CORRESP | Letter to the SEC | Oct 16, 2019 | — |
| CT ORDER | Filing | Oct 3, 2019 | — |
| UPLOAD | Letter from the SEC | Sep 3, 2019 | — |
| DRS | Filing | Aug 20, 2019 | — |
| CT ORDER | Filing | Jul 16, 2019 | — |
| EFFECT | Filing | Apr 17, 2019 | — |
| CORRESP | Letter to the SEC | Apr 15, 2019 | — |
| D | Filing | Mar 28, 2019 | — |
| 25-NSE | Delisting notice | Sep 20, 2018 | — |
| CT ORDER | Filing | Aug 23, 2018 | — |
| POS EX | Filing | Aug 21, 2018 | — |
| EFFECT | Filing | Aug 20, 2018 | — |
| CERT | Filing | Aug 20, 2018 | — |
| CORRESP | Letter to the SEC | Aug 17, 2018 | — |
| CORRESP | Letter to the SEC | Aug 17, 2018 | — |
| 8-A12B/A | Filing | Aug 17, 2018 | — |
| CORRESP | Letter to the SEC | Aug 17, 2018 | — |
| CORRESP | Letter to the SEC | Aug 16, 2018 | — |
| CORRESP | Letter to the SEC | Aug 6, 2018 | — |
| CORRESP | Letter to the SEC | Aug 6, 2018 | — |
| CORRESP | Letter to the SEC | Aug 1, 2018 | — |
| CORRESP | Letter to the SEC | Aug 1, 2018 | — |
| CERT | Filing | Aug 1, 2018 | — |
| 8-A12B | Filing | Jul 31, 2018 | — |
| CORRESP | Letter to the SEC | Jul 27, 2018 | — |
| CORRESP | Letter to the SEC | Jul 27, 2018 | — |
| CORRESP | Letter to the SEC | Jul 13, 2018 | — |
| UPLOAD | Letter from the SEC | Jul 12, 2018 | — |
| CORRESP | Letter to the SEC | Jun 28, 2018 | — |
| UPLOAD | Letter from the SEC | Jun 26, 2018 | — |
| DRSLTR | Filing | Jun 12, 2018 | — |
| DRS/A | Filing | Jun 12, 2018 | — |
| UPLOAD | Letter from the SEC | Jun 8, 2018 | — |
| DRS | Filing | May 14, 2018 | — |
| D | Filing | Jan 27, 2015 | — |
| D | Filing | Jun 27, 2014 | — |
| D | Filing | Jan 8, 2014 | — |
| D | Filing | Oct 2, 2013 | — |
| D | Filing | Jul 5, 2012 | — |
| D | Filing | Mar 24, 2011 | — |
| D | Filing | Apr 27, 2010 | — |
| REGDEX | Auto-generated paper document | Oct 3, 2008 | — |
| REGDEX | Auto-generated paper document | Aug 31, 2007 | — |
Showing 94 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Laboratory Analytical Instruments (SIC 3826)
- Listed as
- BNGO (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Diego, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1411690
- Former names
- BioNano Genomics, Inc (until Oct 20, 2021); Bionano Genomics, Inc (until Oct 20, 2021); BioNanomatrix Inc (until Mar 24, 2011)
Other Laboratory Analytical Instruments companies
- Agilent Technologies, Inc. A
- Waters Corp /DE/ WAT
- Illumina, Inc. ILMN
- Mettler Toledo International INC/ MTD
- Revvity, Inc. RVTY
- Avantor, Inc. AVTR
- Bio-Rad Laboratories, Inc. BIO
- Bruker Corp BRKR
Source: SEC EDGAR filings. This is company-reported data, not investment advice.